Search Results 781-790 of 15281 for pharmacogenetics
Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most[...] ...
See also · Abdominal aortic aneurysm · Acne · Actinic keratosis · Atrial septal defect (ASD) · Autoimmune pancreatitis · Back pain · Benign paroxysmal positional ...
Latest stories · Rare Lyme disease-causing bacteria spotted on routine blood films featured image · Research · Research · Mayo researchers develop algorithm to ...
ROCHESTER, Minn. — Mayo Clinic has been selected to lead a groundbreaking research project focused on improving indoor air quality and safety in healthcare ...
Researchers are leading the nation in developing powerful and precise radiopharmaceutical theranostics intended to treat people with deadly cancers.
The purpose of this study is to define a comprehensive digital phenotype through radio signal-enabled passive environment monitoring, associated with clinical ...
The purpose of the study is to evaluate the safety of Rifaximin or placebo in subjects with severe hepatic impairment and Hepatic Encephalopathy. Participation ...
The purpose of this study is to evaluate the effectiveness of depemokimab 200 mg subcutaneous (SC) given every 6 months versus placebo in participants with ...
About this study. This study consists of two phases: Dose Escalation (Phase 1b) and Dose Expansion (Phase 2) The Dose Escalation phase will evaluate the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.